AstraZeneca rejects 'final' takeover bid from Pfizer

AstraZeneca chairman explains latest Pfizer bid rejection

Related Stories

UK drugs company AstraZeneca has rejected an improved "final" takeover offer from US drugs giant Pfizer.

Pfizer had made a new offer of £55 per share, valuing AstraZeneca at about £69bn.

But AstraZeneca says the new proposal "undervalues the company and its attractive prospects".

Pfizer's pursuit has been under scrutiny because of fears it would hamper AstraZeneca's drug research and cut jobs.

Controversial deal

Start Quote

There is a slight possibility of both coming back to the table with an 'agreed offer' of something in the region of £58 to £60 a share. But no one is holding their breath given the very hostile rejection of AstraZeneca to each of Pfizer's approaches”

End Quote

Pfizer planned to create the world's largest drug company, with its headquarters in New York, but based in the UK for tax purposes.

In a strategy known as "tax inversion" Pfizer could pay the UK corporate tax rate of 20%, rather than the 35% rate applied in the US, if it bought AstraZeneca.

That plan proved controversial with unions and politicians, as AstraZeneca employs 6,700 people in the UK.

AstraZeneca chairman Leif Johansson said Pfizer's pursuit had been "fundamentally driven" by the corporate financial benefits.

"Pfizer has failed to make a compelling strategic, business or value case," he added.

Viagra packet Pfizer's best-known drug is Viagra

Of the two companies' research and development workforce, Pfizer had said it would retain at least 20% in the UK for at least five years. It had also pledged to base its European HQ in Britain.

AstraZeneca's shares fell by more than 13% after its rejection of the offer.

The BBC's business editor Kamal Ahmed said the deal appeared to be over "unless AstraZeneca's shareholders take an astonishingly aggressive stance and force the board to the negotiating table".

In its new offer statement, Pfizer chief executive Ian Read said: "We stand by our unprecedented commitments to the UK government."

Pfizer had said that its improved offer of £55 per share was "final" and would not be increased.

Aberdeen Asset Management's Anne Richards: "We're all trying to weigh up the pros and cons of the deal that's on the table"

AstraZeneca shareholders were being offered £24.76 in cash and 1.747 shares in the new firm - worth a combined £55 - for each share currently they hold.

Pfizer had also promised not to mount a hostile takeover - a direct approach to shareholders of AstraZeneca without the involvement of its board.

Mr Johansson said that he had made clear to Pfizer that his board could only recommend a bid that was at least 10% above an offer of £53.50 made by Pfizer on Friday.

He told Radio 4's Today programme that AstraZeneca had rejected Pfizer's offer for three reasons - that it could create better value for shareholders independently, that a takeover would limit its ability to get drugs to market quickly and that the deal carried a "big execution risk".


Last Updated at 27 Jan 2015, 11:30 ET *Chart shows local time AstraZeneca intraday chart
price change %
4725.00 p +

"It's obviously a controversial deal," he added.

Will Hedden, a trader at spread betting firm IG, said: "With Pfizer saying they won't go hostile, it looks like it is pretty much dead."

Shareholder anger

However, some shareholders said they were frustrated by AstraZeneca's decision to reject the offer.

A fund manager at a firm that is among the top ten investors in AstraZeneca told Reuters he was "extremely disappointed".

"We do not think the Astra management have done a good job on behalf of shareholders," he added.

A second shareholder, within the 40 largest investors in AstraZeneca, said: "I think large numbers of shareholders out there will be disappointed."

Edison Investment Research analyst Mick Cooper said AstraZeneca was banking on getting better returns for shareholders by remaining independent than the cash and share combination that Pfizer has offered.

"AstraZeneca will have six months to demonstrate that it was right to reject Pfizer's offer, or face the prospect of a fresh approach," he said.


More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

More Business stories


Business Live

    07:26: Greece euro exit? BBC Radio 4

    Greece should tell Europe it will not pay its debt and will exit the eurozone, Lord Desai tells Today. He says the country has to decide whether it wants "misery now or misery forever". He suggests that has to be the starting point of any negotiations with the Troika - the IMF, ECB and EU. He adds no country has ever paid debts like this in the past. Germany did not pay all its reparations, he says. "The international community has to recognise you can't put such a incredible burden on a people regardless of whose fault it was," he adds.

    Via Twitter Rory Cellan-Jones Technology correspondent

    tweets: Amazing Apple quarter: record $18bn profit, 74m iPhones - most profitable product in history? But iPads disappoint

    06:57: Greek euro exit? BBC Radio 4

    Lord Desai says most of the debt Greece owes is to public bodies such as the European Union and IMF. Greece cannot continue to pay off its debts for the next 20 years, he adds, and Greece and Germany have to decide whether they can afford for Greece to leave the eurozone. Anne Richardson of Aberdeen Asset Management points out £8bn of bank deposits have left Greek banks since November because investors see a so-called Grexit as having come "one step closer".

    Via Twitter Stephanie McGovern Breakfast business reporter

    tweets: Morning from the Port of Tyne - where today I'm talking about exports. #economy

    06:44: Greek euro exit? BBC Radio 4
    Greece"s Prime Minister Alexis Tsipras is accompanied by associates

    Now that the Greek election has been won by Syriza, thoughts have begun to turn to negotiations over the country's debts. Greece could request to pay no interest on those debts for about five years, Lord Desai, economist and chairman of the Official Monetary and Financial Institutions Forum, tells Today. "That would save them about 4% of GDP," he says. But, he adds, there "really is no human way that Greece can pay the debt without ruining at least one generation's future."

    06:31: GDP growth Radio 5 live

    Anne Richards, chief investment officer of Aberdeen Asset Management is the markets guest on Wake Up to Money. "You have to be a wee bit careful with quarterly numbers as they are subject to a lot of revision," she says. "The overall picture for the year was reasonably positive." Low construction growth was "a bit worrying." Strong sterling is a drag on GDP growth. Reliance on services rather than making things is also a challenge, she says. More engineers are needed.

    06:20: Apple profit Radio 5 live
    The Apple logo

    The biggest quarterly profit ever for a company: $18bn, has been posted by phone pedlars Apple. Daniel Eran Dilger who writes for AppleInsider tells Wake Up to Money. Apple makes a load of margin from its high-end phones. They also make a lot when you break your power cable and have to splurge £65 on a new one, as presenter Adam Parsons learned earlier this week.

    06:12: Services growth Radio 5 live

    More from Greg Madigan, the boss Subway UK and Ireland on Wake Up to Money. Hospitals, service stations and forecourts, or "non-traditional locations" are a big area of growth for the firm, he says. He used to be an air traffic controller, he adds.

    06:01: Services growth Radio 5 live

    Services is what's propping up GDP growth, we learned yesterday. Greg Madigan, the boss Subway UK and Ireland is on Wake Up to Money. "The price of oil has come down putting more money in peoples pocket... one of the things that benefit from more discretionary spending is food retail," he says. They have 2,000 stores in the UK and Ireland now.

    06:00: Howard Mustoe Business reporter

    Good morning. Keep your thoughts on today's news rolling in via email and on twitter @BBCBusiness

    06:00: Matthew West Business Reporter

    Morning everyone. In case you missed it EDF became the last of the "Big Six" energy suppliers to cut its gas prices last night. And US tech giant Apple reported the largest quarterly profit in corporate history. Today sees trading updates come from Brewin Dolphin, Johnson Matthey, Sage and Anglo American. We'll bring you those numbers and more as we get them.



Copyright © 2015 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.